Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
scibac Logo
scibac Growth Score
26
CB Rank
49832
Heat Score
51
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
Founded
obfuscation
PrivateGrant Burlingame, California, United States1-10 www.scibac.com/
Biotechnology
Health Care
Therapeutics
Overview

scibac
Total Funding
obfuscation
Growth Score
26
Heat Score
51

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score26
-3 pts
in past quarter
Heat Score 51
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About scibac

CB Rank
49832
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
Founded
obfuscation
PrivateGrant Burlingame, California, United States1-10 www.scibac.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name SCIBAC INC.
Operating Status Active
Company Type For Profit
Founders  Anthony Cann, Derik Twomey, Jeanette Mucha
About the Company

SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.The company's technology improves beneficial microorganisms using a patented MERGE platform that uses a type of directed evolution to increase therapeutic efficacy. Its first two therapeutics treat chronic infections in cystic fibrosis for Pseudomonas, Staph,

Burkholderia, and NTM.

Phone Number (650) 689-5343
Contact Email INFO@SCIBAC.COM
Diversity Spotlight 
Women Founded
Women Led
Predictions & Insights

Products & Services

Flow Nanoanalyzer
An instrument designed for analyzing nanoparticles using flow cytometry techniques.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - scibac Logo
Grant - scibac
1
obfuscation
National Institutes of HealthGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - scibac Logo
Grant - scibac
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - scibac Logo
Grant - scibac
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - scibac Logo
Grant - scibac
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - scibac Logo
Grant - scibac
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - scibac Logo
Grant - scibac
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 3

Employee Profiles

News
Technology
View Tech Report

IT Spend

$130.2KThis year, scibac is projected to spend $130.2K on IT, according to Aberdeen.

Actively Used Products

9scibac uses 9 technology products and services including HTML5, Google Analytics, and  Google Fonts, according to G2 Stack.

Active Website Tech Count

3scibac is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, IPhone / Mobile Compatible, and  CommonCrawl Top 50m.

Total IP

2The intellectual property of scibac includes 2 registered patents primarily in the 'Testing' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is scibac's headquarters? scibac is located in Burlingame, California, United States.Who invested in scibac? scibac has 3 investors including National Institutes of Health and  Breakout Labs.When was the last funding round for scibac? scibac closed its last funding round on
obfuscation
from a Grant round.Who are scibac's competitors? Alternatives and possible competitors to scibac may include Ferring, MaaT Pharma, and  Vedanta Biosciences.How much funding has scibac raised to date? scibac has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|